Y0002099

Moxifloxacin for peak identification A

European Pharmacopoeia (EP) Reference Standard

• 別名: Moxifloxacin, 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• 実験式（ヒル表記法）: C₂₁H₂₄FN₃O₄
• CAS番号: 151096-09-2
• 分子量: 401.43
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• APIファミリー: moxifloxacin
• メーカー／製品名: EDQM
• アプリケーション: pharmaceutical
• 保管温度: 2-8°C
• SMILES記法: Fc1cc2c(c(c1N4C[C@H]5[N+H2]CCC[C@H]5C4)OC)N(C=C(C2=O)C(=O)[O-])C3CC3
• InChI: 1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1
• InChI Key: FABPRXSRWADJSP-MEDUHNTESA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Moxifloxacin for peak identification A EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS07,GHS09
• シグナルワード: Warning
• 危険有害性情報: H302,H319,H411
• 注意書き: P273 - P301 + P312 + P330 - P305 + P351 + P338
• 危険有害性の分類: Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 2
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable